Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × Cholecystolithiasis × NET × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 2 NET 1 Head & Neck 1 Endocrine 1

Conditions

Neuroendocrine Tumors 47 Gastrointestinal Neoplasms 6 Stomach Neoplasms 5 Pancreatic Neoplasms 5 Carcinoma, Hepatocellular 5 Colorectal Neoplasms 4 Rectal Neuroendocrine Tumor 3 Prostatic Neoplasms 3 Neoplasm Metastasis 3 Liver Neoplasms 3 Esophageal Neoplasms 3 Thyroid Neoplasms 2 Rectal Neoplasms 2 Neoplasms 2 Gastrointestinal Stromal Tumors 2 Gastro-enteropancreatic neuroendocrine tumor 2 Colonic Neoplasms 2 Cholangiocarcinoma 2 Carcinoma, Neuroendocrine 2 Carcinoma 2 Carcinoid Tumor 2 Biliary Tract Neoplasms 2 Appendiceal Neoplasms 2 Anus Neoplasms 2 Visceral Pain 1 Serotonin Syndrome 1 Recurrence 1 Rectal Neuroendocrine Tumors 1 Pheochromocytoma 1 Patients With Gastroenteropancreatic Neuroendocrine Tumors 1

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04735198 2025-05-20

TNE-IDC-COLE

Hospital Universitari de Bellvitge

Phase NA Recruiting

Neuroendocrine Tumors, Cholecystolithiasis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡